Cargando…
Radiotherapy Dose and Induction Chemotherapy Cycles Are Associated With Prognosis and Toxicity Risk: A Retrospective Study of 227 Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
OBJECTIVE: Concurrent chemoradiation (cCHRT) has been confirmed as the standard treatment for local advanced non-small-cell lung cancer (NSCLC). This study is to assess the appropriate timing of radiotherapy and cycles of induction chemotherapy for those patients. METHODS: 227 inoperable stage III N...
Autores principales: | Chen, Liyao, Hou, Yu, Xia, Yaoxiong, Chang, Li, Diao, Xianmin, Wang, Li, Li, Lan, Long, Qing, Liu, Ying, Liu, Yan, Li, Wenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592313/ https://www.ncbi.nlm.nih.gov/pubmed/33073689 http://dx.doi.org/10.1177/1533033820951802 |
Ejemplares similares
-
The role of radiotherapy-related autophagy genes in the prognosis and immune infiltration in lung adenocarcinoma
por: Gao, Jingyan, et al.
Publicado: (2022) -
Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database
por: Yacouba, Mohamed Bassirou Moukeila, et al.
Publicado: (2023) -
Combined Radiomics–Clinical Model to Predict Radiotherapy Response in Inoperable Stage III and IV Non-Small-Cell Lung Cancer
por: Chen, Wenrui, et al.
Publicado: (2022) -
Mean platelet volume predicts chemotherapy response and prognosis in patients with unresectable gastric cancer
por: LIAN, LIAN, et al.
Publicado: (2015) -
The Application and Development of Deep Learning in Radiotherapy: A Systematic Review
por: Huang, Danju, et al.
Publicado: (2021)